Related Experiment Video

Updated: Dec 27, 2025

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

7.7K

Germline and Somatic Testing in Ovarian Cancer: Shifting Sands of Recommendations

Kathleen N Moore, Kristin K Zorn

    Gynecologic Oncology
    |March 5, 2020
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    In Vivo and Ex Vivo Approaches to Study Ovarian Cancer Metastatic Colonization of Milky Spot Structures in Peritoneal Adipose
    13:04

    In Vivo and Ex Vivo Approaches to Study Ovarian Cancer Metastatic Colonization of Milky Spot Structures in Peritoneal Adipose

    Published on: October 14, 2015

    13.7K
    Visualizing DNA Damage Repair Proteins in Patient-Derived Ovarian Cancer Organoids via Immunofluorescence Assays
    04:07

    Visualizing DNA Damage Repair Proteins in Patient-Derived Ovarian Cancer Organoids via Immunofluorescence Assays

    Published on: February 24, 2023

    2.1K

    Related Experiment Videos

    Last Updated: Dec 27, 2025

    Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
    10:27

    Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

    Published on: July 25, 2020

    7.7K
    In Vivo and Ex Vivo Approaches to Study Ovarian Cancer Metastatic Colonization of Milky Spot Structures in Peritoneal Adipose
    13:04

    In Vivo and Ex Vivo Approaches to Study Ovarian Cancer Metastatic Colonization of Milky Spot Structures in Peritoneal Adipose

    Published on: October 14, 2015

    13.7K
    Visualizing DNA Damage Repair Proteins in Patient-Derived Ovarian Cancer Organoids via Immunofluorescence Assays
    04:07

    Visualizing DNA Damage Repair Proteins in Patient-Derived Ovarian Cancer Organoids via Immunofluorescence Assays

    Published on: February 24, 2023

    2.1K

    Related Concept Videos

    Cancer-Critical Genes II: Tumor Suppressor Genes01:05

    Cancer-Critical Genes II: Tumor Suppressor Genes

    9.3K
    Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
    When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
    Such genes that act...
    9.3K

    Articles linked to this work by shared authors, journal, and citation graph.

    Long-term efficacy and safety of avutometinib + defactinib in recurrent low-grade serous ovarian cancer: Results of a 2-year follow-up of ENGOT-OV60/GOG-3052/RAMP 201.

    Gynecologic oncology·2026

    The Vanguard Study: Assessing feasibility of conducting randomized trials of novel multi-cancer detection tests.

    Contemporary clinical trials·2026

    Antibody drug conjugates in gynaecological cancers: navigating between opportunities and challenges.

    EClinicalMedicine·2026

    Phase 1/2 study of IMC-C103C, a T cell receptor bispecific (MAGE-A4×CD3) ImmTAC targeting MAGE-A4-expressing malignancies.

    Journal for immunotherapy of cancer·2026

    MLH1 promoter hypermethylation and associations with survival outcomes: A real-world endometrial cancer molecularly targeted therapy consortium cohort study.

    Gynecologic oncology·2026

    Updated patient-reported outcomes and the effect of disease progression on health-related quality of life in the PRIMA/ENGOT-OV26/GOG-3012 trial of niraparib first-line maintenance therapy in patients with newly diagnosed advanced ovarian cancer.

    Gynecologic oncology·2026

    Concordance between gastric HER2 scores for endometrial sampling versus hysterectomy specimens in endometrial cancer.

    Gynecologic oncology·2026

    Association of community-level social vulnerability with county-level clinical trial access among ovarian cancer patients.

    Gynecologic oncology·2026

    Feasibility of real-time near-infrared fluorescence tracer imaging in sentinel lymph node biopsy for vulvar cancer patients.

    Gynecologic oncology·2026

    Impact of palliative radiotherapy in patients with gynecologic malignancies on end-of-life outcomes.

    Gynecologic oncology·2026

    Contemporary surgical management of vulvar cancer is associated with improved survival but increased reoperation rate: A Finnish nationwide study.

    Gynecologic oncology·2026

    A phase II study in newly diagnosed stage III/IV epithelial ovarian cancer evaluating carboplatin/taxol/pembrolizumab in patients receiving neoadjuvant chemotherapy followed by pembrolizumab maintenance with or without olaparib.

    Gynecologic oncology·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us